Patent ID: 11859255
Assignee: TORAY INDUSTRIES, INC.
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 0:
1. A method for detecting breast cancer in a human subject, comprising:
measuring expression level of hsa-miR-4730 in a blood, serum or plasma sample from the subject,
comparing the measured expression level of hsa-miR-4730 to a control expression level for a healthy subject;
detecting a decreased level of hsa-miR-4730 in the sample from the subject as compared to the control expression level from the sample from the healthy subject;
wherein the decreased level of hsa-miR-4730 indicates that the subject has breast cancer; and
wherein the method further comprises treating the subject for the breast cancer or performing a diagnostic procedure on the subject with the breast cancer;
wherein the treatment comprises surgery, radiotherapy, chemotherapy or a combination thereof; and
wherein the diagnostic procedure comprises mammography, ultrasonography, CT, MRI, abdominal ultrasonography, bone scintigraphy, PET, pathological examination which involves analyzing a lesion tissue under a microscope, or a combination thereof.